AI Tech in Baltimore Lab Learns to Forecast Stock Prices (See its Live Calls on NVDA, AMZN, TSLA - For Free)

The same AI tech being used to save 50 lives per year in California hospitals has now learned to forecast U.S. stock prices with remarkable results.

Popular

AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial

AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.

Why Is a $116B Mining Giant Backing a $10M Firm? - Ad

Rio Tinto rarely makes early-stage bets. Yet one small N. American firm earned its trust with projects in lithium, uranium, and titanium - all vital to U.S. defense and energy independence.

AP Lifestyles Digest for week of Nov. 10

Here is the AP Lifestyles Digest for the week of Nov. 10. Note AP's Holiday Gift Guide Digest is included at the end; the gift guides move Wednesday.

Legally "Skim" $6,361 Into Your Account? - Ad

A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.

A deal to end the government shutdown is on track but faces hurdles

WASHINGTON (AP) — A legislative package to end appears on track Monday after a handful of Senate Democrats joined with Republicans to break the impasse in what has become of federal , the longest in history.

Baxter Warns Of Potential Device Tampering In Life2000 Ventilator Recall

Baxter recalls its Life2000 ventilators after a cybersecurity flaw prompts an FDA high-risk alert, urging patients to stop use and seek replacement options.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after January 29, it may be too late.

Trump EPA moves to abandon rule that sets tough standards for deadly soot pollution

WASHINGTON (AP) — The Trump administration is seeking to abandon a rule that sets tough standards for deadly , arguing that the Biden administration did not have authority to set the tighter standard on pollution from tailpipes, smokestacks and other industrial sources.

Small Caps, Pharma Surge As AI Rotation Broadens, Nvidia Tumbles: What's Moving Markets Tuesday?

Wall Street's sector rotation entered full throttle Tuesday, with investors pouring into previously overlooked corners of the market amid an AI-driven shift that now favors undervalued small caps and defensive names such as health care.

Global Demand for Defense Metals Is Surging 7X - Ad

Lithium, uranium and titanium are at the center of a global race. Nations are scrambling to secure them for fighter jets, EVs, and reactors. One N. American project could help fill the West's critical-minerals gap.

AP Lifestyles Digest for week of Nov. 24

Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.

AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows

AstraZeneca boosts its Harbour BioMed collaboration and invests $2 billion to expand biologics manufacturing and clinical development capacity in Maryland.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Plan for $20 million firefighter training center near the site of Ohio derailment revived

Norfolk Southern railroad worked with the state of Ohio and Youngstown State University to revive plans for a $20 million first responder training center near the site of the in East Palestine, Ohio.

AI Tech in Baltimore Lab Learns to Forecast Stock Prices (See its Live Calls on NVDA, AMZN, TSLA - For Free) - Ad

The same AI tech being used to save 50 lives per year in California hospitals has now learned to forecast U.S. stock prices with remarkable results.

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets.

Activist Investor Drops Scathing Letter, Slams Cooper's 'Growth At All Costs' Approach

Browning West urges changes for underperforming Cooper Companies, highlighting weak oversight and misaligned incentives.

The Stock-Picking AI That Could Triple Your Money This Year - Ad

Early users could have already tripled their money every single year this AI has been live, based on the average winning trade spotted - WITHOUT having to check the news, WITHOUT watching the Fed, and WITHOUT all the stress most traders have to deal with. For now, you can try this AI yourself, completely free of charge - no email, no credit card.

As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves

As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the on some store shelves.

Guterres and Lula to push negotiators at COP30 as deadline looms

BELEM, Brazil (AP) — Two global power players will spend Wednesday pushing negotiators to find compromises at in Brazil’s Belém, where a self-imposed deadline is rushing up fast.

Elon's Optimus to Mint New "Musk Millionaires" as Soon as Jan 26? - Ad

Elon Musk may be set to create more "Musk Millionaires" as soon as January 26... Because on that day, he's expected to officially launch his Optimus robot... An AI-powered robot that Elon himself says will be capable of "doing anything bar nothing". Now, it's important to point out that Elon hasn't released it to the public yet... But ahead of the launch, one Silicon Valley insider has identified a "backdoor way" for any American to invest in Optimus with a regular brokerage account...

Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer

Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and monotherapy. Clinical trial data show superior results.

Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers

A U.S. Bankruptcy Court judge is set to give his reasoning Tuesday for approving OxyContin maker Purdue Pharma's plan to settle thousands of lawsuits over the toll of opioids.

Nvidia Has $24 Trillion in Their Sights - Ad

Nvidia's pivoting to the next tech frontiers they intend to conquer. But they can't do it by themselves. Nvidia is counting on these three companies that many people won't know the name of. Not even the savviest of investors. But Michael Robinson does.

AP Lifestyles Digest for week of Nov. 17

Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.

As nations push for more ambition at climate talks, chairman says they may get it

BELEM, Brazil (AP) — Going into , the Brazilian hosts weren’t looking for big end-of-session pronouncements on lofty goals. This conference was supposed to hyperfocus on “implementation” of .

The U.S. Wants Metal Independence - And This Nevada Opportunity Fits the Moment - Ad

Washington's push for domestic copper, silver, gold, and tungsten is reshaping the resource landscape. Their neighbor's multi-metal hits, supported by $6M in federal funding and a 300%+ YTD surge, confirmed this Nevada corridor is the right kind of ground. Now another early-stage explorer has stepped into the same trend as interest accelerates.

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

Why Is a $116B Mining Giant Backing a $10M Firm? - Ad

Rio Tinto rarely makes early-stage bets. Yet one small N. American firm earned its trust with projects in lithium, uranium, and titanium - all vital to U.S. defense and energy independence.

Workers take on side jobs to combat stagnant salaries and insecurity about employment

NEW YORK (AP) — As workers face , inflation and , some have decided to branch out from their traditional careers. They're taking on side jobs to bring in additional income and provide a backup plan should they , or adding second, third and sometimes fourth jobs — what some call “polyworking” — to the mix.

Federal workers question whether the longest government shutdown was worth their sacrifice

WASHINGTON (AP) — Jessica Sweet spent cutting back. To make ends meet, the Social Security claims specialist drank only one coffee a day, skipped meals, cut down on groceries and deferred paying some household bills. She racked up spending on her credit card buying gas to get to work.

Legally "Skim" $6,361 Into Your Account? - Ad

A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

More than 80 nonprofits receive $250M for global women's health from Melinda French Gates

More than 80 organizations that provide health care for women all over the world received grants Wednesday totaling after a year-long application process.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service